Pasar al contenido principal

FUNCION Y ANALISIS DE LOS MICROEXONES EN CELULAS DIFERENCIADAS (FOTORECEPTORAS) Y EN CANCER

PGC2018-101271-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO CENTRE DE REGULACIO GENOMICA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Using protein-per-mRNA differences among human tissues in codon optimization

  • Hernandez-Alias, Xavier
  • Benisty, Hannah, 1986-
  • Radusky, Leandro
  • Serrano Pubull, Luis, 1982-
  • Schaefer, Martin H.
Background: Codon usage and nucleotide composition of coding sequences have profound effects on protein expression. However, while it is recognized that different tissues have distinct tRNA profiles and codon usages in their transcriptomes, the effect of tissue-specific codon optimality on protein synthesis remains elusive. Results: We leverage existing state-of-the-art transcriptomics and proteomics datasets from the GTEx project and the Human Protein Atlas to compute the protein-to-mRNA ratios of 36 human tissues. Using this as a proxy of translational efficiency, we build a machine learning model that identifies codons enriched or depleted in specific tissues. We detect two clusters of tissues with an opposite pattern of codon preferences. We then use these identified patterns for the development of CUSTOM, a codon optimizer algorithm which suggests a synonymous codon design in order to optimize protein production in a tissue-specific manner. In human cell-line models, we provide evidence that codon optimization should take into account particularities of the translational machinery of the tissues in which the target proteins are expressed and that our approach can design genes with tissue-optimized expression profiles. Conclusions: We provide proof-of-concept evidence that codon preferences exist in tissue-specific protein synthesis and demonstrate its application to synthetic gene design. We show that CUSTOM can be of benefit in biological and biotechnological applications, such as in the design of tissue-targeted therapies and vaccines., We acknowledge the support of the Spanish Ministry of Science and Innovation (MICINN) (PGC2018-101271-B-I00 Plan Estatal), ‘Centro de Excelencia Severo Ochoa’, and the CERCA Programme/Generalitat de Catalunya. The work of X.H. has been supported by a PhD fellowship from the Fundación Ramón Areces. The work leading to this manuscript was supported by Fondazione AIRC, grant reference number MFAG 21791, and partially supported by the Italian Ministry of Health with Ricerca Corrente and 5x1000 funds.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Unique transcriptomes of sensory and non-sensory neurons: insights from Splicing Regulatory States

  • Ciampi, Ludovica
  • Serrano Pubull, Luis, 1982-
  • Irimia Martínez, Manuel
Alternative Splicing (AS) programs serve as instructive signals of cell type specificity, particularly within the brain, which comprises dozens of molecularly and functionally distinct cell types. Among them, retinal photoreceptors stand out due to their unique transcriptome, making them a particularly well-suited system for studying how AS shapes cell type-specific molecular functions. Here, we use the Splicing Regulatory State (SRS) as a novel framework to discuss the splicing factors governing the unique AS pattern of photoreceptors, and how this pattern may aid in the specification of their highly specialized sensory cilia. In addition, we discuss how other sensory cells with ciliated structures, for which data is much scarcer, also rely on specific SRSs to implement a proteome specialized in the detection of sensory stimuli. By reviewing the general rules of cell type- and tissue-specific AS programs, firstly in the brain and subsequently in specialized sensory neurons, we propose a novel paradigm on how SRSs are established and how they can diversify. Finally, we illustrate how SRSs shape the outcome of mutations in splicing factors to produce cell type-specific phenotypes that can lead to various human diseases., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme. This work has been funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (ERC-CoG-LS2-101002275 to MI), the Spanish Ministerio de Ciencia (BFU2017-89201-P to MI and PGC2018-101271-B-I00 to LS).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

robustica: customizable robust independent component analysis

  • Anglada-Girotto, Miquel
  • Miravet Verde, Samuel, 1992-
  • Serrano Pubull, Luis, 1982-
  • Head, Sarah A.
Background: Independent Component Analysis (ICA) allows the dissection of omic datasets into modules that help to interpret global molecular signatures. The inherent randomness of this algorithm can be overcome by clustering many iterations of ICA together to obtain robust components. Existing algorithms for robust ICA are dependent on the choice of clustering method and on computing a potentially biased and large Pearson distance matrix. Results: We present robustica, a Python-based package to compute robust independent components with a fully customizable clustering algorithm and distance metric. Here, we exploited its customizability to revisit and optimize robust ICA systematically. Of the 6 popular clustering algorithms considered, DBSCAN performed the best at clustering independent components across ICA iterations. To enable using Euclidean distances, we created a subroutine that infers and corrects the components' signs across ICA iterations. Our subroutine increased the resolution, robustness, and computational efficiency of the algorithm. Finally, we show the applicability of robustica by dissecting over 500 tumor samples from low-grade glioma (LGG) patients, where we define two new gene expression modules with key modulators of tumor progression upon IDH1 and TP53 mutagenesis. Conclusion: robustica brings precise, efficient, and customizable robust ICA into the Python toolbox. Through its customizability, we explored how different clustering algorithms and distance metrics can further optimize robust ICA. Then, we showcased how robustica can be used to discover gene modules associated with combinations of features of biological interest. Taken together, given the broad applicability of ICA for omic data analysis, we envision robustica will facilitate the seamless computation and integration of robust independent components in large pipelines., This project was funded by grants from the Plan Estatal de Investigación Científica y Técnica y de Innovación to L.S. (PGC2018-101271-B-I00 and PID2021-122341NB-I00, http://www.ciencia.gob.es). We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya. These funding bodies have not participated in the design of the study, collection, analysis, and interpretation of the data, nor in writing the manuscript.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications

  • Anglada-Girotto, Miquel
  • Ciampi, Ludovica
  • Bonnal, Sophie
  • Head, Sarah A.
  • Miravet Verde, Samuel, 1992-
  • Serrano Pubull, Luis, 1982-
Alternative splicing is crucial for cancer progression and can be targeted pharmacologically, yet identifying driver exons genome-wide remains challenging. We propose identifying such exons by associating statistically gene-level cancer dependencies from knockdown viability screens with splicing profiles and gene expression. Our models predict the effects of splicing perturbations on cell proliferation from transcriptomic data, enabling in silico RNA screening and prioritizing targets for splicing-based therapies. We identified 1,073 exons impacting cell proliferation, many from genes not previously linked to cancer. Experimental validation confirms their influence on proliferation, especially in highly proliferative cancer cell lines. Integrating pharmacological screens with splicing dependencies highlights the potential driver exons affecting drug sensitivity. Our models also allow predicting treatment outcomes from tumor transcriptomes, suggesting applications in precision oncology. This study presents an approach to identifying cancer driver exon and their therapeutic potential, emphasizing alternative splicing as a cancer target., We thank Carolina Segura-Morales for the support in the experimental validations. We thank Javier Delgado and Damiano Cianferoni for their support in the structural analyzes. Also, we thank Juan Valcárcel, Manuel Irimia, Donate Weghorn, Xavier Hernandez-Alias, Marc Weber, and Reza Sodaei for the insightful discussions and feedback provided throughout the development of this project. We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme and to the EMBL partnership. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. The results shown here are in part based upon data generated by the TCGA Research Network (https://www.cancer.gov/tcga) and by Helsinki University (EGAD00001006456). Finally, we would like to thank the developer team behind VastDB as they created a resource that unifies and facilitates the splicing event-centric analysis of transcriptomes from the computational to the experimental sides. This project was funded by grants from the Plan Estatal de Investigación Científica y Técnica y de Innovación: PGC2018-101271-B-I00 and PID2021-122341NB-I00, (AEI/FEDER, UE) to L.S., and PID2021-122341NB-I00 project funded MICIU /AEI /10.13039/501100011033 / (FEDER, UE) to L.S.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Silencing of SRRM4 suppresses microexon inclusion and promotes tumor growth across cancers

  • Head, Sarah A.
  • Hernández-Alias, Xavier
  • Yang, Jae-Seong
  • Ciampi, Ludovica
  • Beltrán-Sastre, Violeta
  • Torres-Méndez, Antonio
  • Irimia, Manuel
  • Schaefer, Hanno
  • Serrano, Luis
RNA splicing is widely dysregulated in cancer, frequently due to altered expression or activity of splicing factors (SFs). Microexons are extremely small exons (3–27 nucleotides long) that are highly evolutionarily conserved and play critical roles in promoting neuronal differentiation and development. Inclusion of microexons in mRNA transcripts is mediated by the SF Serine/Arginine Repetitive Matrix 4 (SRRM4), whose expression is largely restricted to neural tissues. However, microexons have been largely overlooked in prior analyses of splicing in cancer, as their small size necessitates specialized computational approaches for their detection. Here, we demonstrate that despite having low expression in normal nonneural tissues, SRRM4 is further silenced in tumors, resulting in the suppression of normal microexon inclusion. Remarkably, SRRM4 is the most consistently silenced SF across all tumor types analyzed, implying a general advantage of microexon down-regulation in cancer independent of its tissue of origin. We show that this silencing is favorable for tumor growth, as decreased SRRM4 expression in tumors is correlated with an increase in mitotic gene expression, and up-regulation of SRRM4 in cancer cell lines dose-dependently inhibits proliferation in vitro and in a mouse xenograft model. Further, this proliferation inhibition is accompanied by induction of neural-like expression and splicing patterns in cancer cells, suggesting that SRRM4 expression shifts the cell state away from proliferation and toward differentiation. We therefore conclude that SRRM4 acts as a proliferation brake, and tumors gain a selective advantage by cutting off this brake., This project was funded in part by a grant from the Plan Estatal de Investigación Científica y Técnica y de Innovación to L.S. (PGC2018-101271-B-I00, http://www.ciencia.gob.es). S.A.H. is supported by a Marie Skłodowska-Curie Individual Fellowship from the European Union’s Horizon 2020 research and innovation programme (MSCA-IF-2017-794629, http://ec.europa.eu/). X.H. is supported by a PhD fellowship from the Fundación Ramón Areces (http://www.fundacionareces.es). We acknowledge the support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa’, the CERCA Programme / Generalitat de Catalunya, and the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications

  • Anglada-Girotto, Miquel
  • Ciampi, Ludovica
  • Bonnal, Sophie
  • Head, Sarah A.
  • Miravet Verde, Samuel, 1992-
  • Serrano Pubull, Luis, 1982-
Alternative splicing is crucial for cancer progression and can be targeted pharmacologically, yet identifying driver exons genome-wide remains challenging. We propose identifying such exons by associating statistically gene-level cancer dependencies from knockdown viability screens with splicing profiles and gene expression. Our models predict the effects of splicing perturbations on cell proliferation from transcriptomic data, enabling in silico RNA screening and prioritizing targets for splicing-based therapies. We identified 1,073 exons impacting cell proliferation, many from genes not previously linked to cancer. Experimental validation confirms their influence on proliferation, especially in highly proliferative cancer cell lines. Integrating pharmacological screens with splicing dependencies highlights the potential driver exons affecting drug sensitivity. Our models also allow predicting treatment outcomes from tumor transcriptomes, suggesting applications in precision oncology. This study presents an approach to identifying cancer driver exon and their therapeutic potential, emphasizing alternative splicing as a cancer target., We thank Carolina Segura-Morales for the support in the experimental validations. We thank Javier Delgado and Damiano Cianferoni for their support in the structural analyzes. Also, we thank Juan Valcárcel, Manuel Irimia, Donate Weghorn, Xavier Hernandez-Alias, Marc Weber, and Reza Sodaei for the insightful discussions and feedback provided throughout the development of this project. We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI /10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme and to the EMBL partnership. We are grateful to the CRG Core Technologies Programme for their support and assistance in this work. The results shown here are in part based upon data generated by the TCGA Research Network (https://www.cancer.gov/tcga) and by Helsinki University (EGAD00001006456). Finally, we would like to thank the developer team behind VastDB as they created a resource that unifies and facilitates the splicing event-centric analysis of transcriptomes from the computational to the experimental sides. This project was funded by grants from the Plan Estatal de Investigación Científica y Técnica y de Innovación: PGC2018-101271-B-I00 and PID2021-122341NB-I00, (AEI/FEDER, UE) to L.S., and PID2021-122341NB-I00 project funded MICIU /AEI /10.13039/501100011033 / (FEDER, UE) to L.S.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Unique transcriptomes of sensory and non-sensory neurons: insights from Splicing Regulatory States

  • Ciampi, Ludovica
  • Serrano Pubull, Luis, 1982-
  • Irimia Martínez, Manuel
Alternative Splicing (AS) programs serve as instructive signals of cell type specificity, particularly within the brain, which comprises dozens of molecularly and functionally distinct cell types. Among them, retinal photoreceptors stand out due to their unique transcriptome, making them a particularly well-suited system for studying how AS shapes cell type-specific molecular functions. Here, we use the Splicing Regulatory State (SRS) as a novel framework to discuss the splicing factors governing the unique AS pattern of photoreceptors, and how this pattern may aid in the specification of their highly specialized sensory cilia. In addition, we discuss how other sensory cells with ciliated structures, for which data is much scarcer, also rely on specific SRSs to implement a proteome specialized in the detection of sensory stimuli. By reviewing the general rules of cell type- and tissue-specific AS programs, firstly in the brain and subsequently in specialized sensory neurons, we propose a novel paradigm on how SRSs are established and how they can diversify. Finally, we illustrate how SRSs shape the outcome of mutations in splicing factors to produce cell type-specific phenotypes that can lead to various human diseases., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033), and the Generalitat de Catalunya through the CERCA programme. This work has been funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (ERC-CoG-LS2-101002275 to MI), the Spanish Ministerio de Ciencia (BFU2017-89201-P to MI and PGC2018-101271-B-I00 to LS).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

robustica: customizable robust independent component analysis

  • Anglada-Girotto, Miquel
  • Miravet Verde, Samuel, 1992-
  • Serrano Pubull, Luis, 1982-
  • Head, Sarah A.
Background: Independent Component Analysis (ICA) allows the dissection of omic datasets into modules that help to interpret global molecular signatures. The inherent randomness of this algorithm can be overcome by clustering many iterations of ICA together to obtain robust components. Existing algorithms for robust ICA are dependent on the choice of clustering method and on computing a potentially biased and large Pearson distance matrix. Results: We present robustica, a Python-based package to compute robust independent components with a fully customizable clustering algorithm and distance metric. Here, we exploited its customizability to revisit and optimize robust ICA systematically. Of the 6 popular clustering algorithms considered, DBSCAN performed the best at clustering independent components across ICA iterations. To enable using Euclidean distances, we created a subroutine that infers and corrects the components' signs across ICA iterations. Our subroutine increased the resolution, robustness, and computational efficiency of the algorithm. Finally, we show the applicability of robustica by dissecting over 500 tumor samples from low-grade glioma (LGG) patients, where we define two new gene expression modules with key modulators of tumor progression upon IDH1 and TP53 mutagenesis. Conclusion: robustica brings precise, efficient, and customizable robust ICA into the Python toolbox. Through its customizability, we explored how different clustering algorithms and distance metrics can further optimize robust ICA. Then, we showcased how robustica can be used to discover gene modules associated with combinations of features of biological interest. Taken together, given the broad applicability of ICA for omic data analysis, we envision robustica will facilitate the seamless computation and integration of robust independent components in large pipelines., This project was funded by grants from the Plan Estatal de Investigación Científica y Técnica y de Innovación to L.S. (PGC2018-101271-B-I00 and PID2021-122341NB-I00, http://www.ciencia.gob.es). We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya. These funding bodies have not participated in the design of the study, collection, analysis, and interpretation of the data, nor in writing the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Using protein-per-mRNA differences among human tissues in codon optimization

  • Hernandez-Alias, Xavier
  • Benisty, Hannah, 1986-
  • Radusky, Leandro
  • Serrano Pubull, Luis, 1982-
  • Schaefer, Martin H.
Background: Codon usage and nucleotide composition of coding sequences have profound effects on protein expression. However, while it is recognized that different tissues have distinct tRNA profiles and codon usages in their transcriptomes, the effect of tissue-specific codon optimality on protein synthesis remains elusive. Results: We leverage existing state-of-the-art transcriptomics and proteomics datasets from the GTEx project and the Human Protein Atlas to compute the protein-to-mRNA ratios of 36 human tissues. Using this as a proxy of translational efficiency, we build a machine learning model that identifies codons enriched or depleted in specific tissues. We detect two clusters of tissues with an opposite pattern of codon preferences. We then use these identified patterns for the development of CUSTOM, a codon optimizer algorithm which suggests a synonymous codon design in order to optimize protein production in a tissue-specific manner. In human cell-line models, we provide evidence that codon optimization should take into account particularities of the translational machinery of the tissues in which the target proteins are expressed and that our approach can design genes with tissue-optimized expression profiles. Conclusions: We provide proof-of-concept evidence that codon preferences exist in tissue-specific protein synthesis and demonstrate its application to synthetic gene design. We show that CUSTOM can be of benefit in biological and biotechnological applications, such as in the design of tissue-targeted therapies and vaccines., We acknowledge the support of the Spanish Ministry of Science and Innovation (MICINN) (PGC2018-101271-B-I00 Plan Estatal), ‘Centro de Excelencia Severo Ochoa’, and the CERCA Programme/Generalitat de Catalunya. The work of X.H. has been supported by a PhD fellowship from the Fundación Ramón Areces. The work leading to this manuscript was supported by Fondazione AIRC, grant reference number MFAG 21791, and partially supported by the Italian Ministry of Health with Ricerca Corrente and 5x1000 funds.